Cerity Partners LLC Sells 1,844 Shares of Exponent, Inc. (NASDAQ:EXPO)

Cerity Partners LLC cut its holdings in Exponent, Inc. (NASDAQ:EXPO) by 8.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,979 shares of the business services provider’s stock after selling 1,844 shares during the period. Cerity Partners LLC’s holdings in Exponent were worth $1,780,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Exponent by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock worth $476,284,000 after acquiring an additional 67,296 shares in the last quarter. Geode Capital Management LLC grew its holdings in Exponent by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 1,519,584 shares of the business services provider’s stock valued at $135,419,000 after purchasing an additional 13,932 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Exponent by 0.6% in the fourth quarter. Wells Fargo & Company MN now owns 739,710 shares of the business services provider’s stock valued at $65,908,000 after purchasing an additional 4,704 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Exponent during the 4th quarter worth $55,131,000. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Price Performance

Exponent stock opened at $79.39 on Thursday. Exponent, Inc. has a fifty-two week low of $73.83 and a fifty-two week high of $115.75. The firm has a fifty day moving average price of $82.87 and a two-hundred day moving average price of $92.71. The firm has a market cap of $4.03 billion, a price-to-earnings ratio of 37.45 and a beta of 0.84.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the firm posted $0.41 earnings per share. As a group, sell-side analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Activity

In related news, VP Richard Reiss sold 1,736 shares of the company’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.10% of the stock is owned by company insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.